Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gero Brockhoff

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Current Protocols|November 20, 2023
Complementary Tumor Diagnosis by Single Cell-Based Cytogenetics Using Multi-marker Fluorescence In Situ Hybridization (mFISH)Gero Brockhoff
Oncotarget|May 30, 2019
Target HER four in breast cancer?Gero Brockhoff
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Cytomics and receptor interaction]Gero Brockhoff
Cellular Signalling|July 12, 2022
"Shedding" light on HER4 signaling in normal and malignant breast tissuesGero Brockhoff
Current Protocols in Cytometry|September 5, 2008
Flow cytometric FRET analysis of ErbB receptor tyrosine kinase interactionSimone Diermeier-Daucher, Gero Brockhoff
Current Protocols in Cell Biology|September 21, 2010
Dynamic proliferation assessment in flow cytometrySimone Diermeier-Daucher, Gero Brockhoff
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 13, 2012
Targeting drugs to mitochondriaAnne Heller, Gero Brockhoff, Achim Goepferich
Annals of the New York Academy of Sciences|July 4, 2008
Flow cytometric FRET analysis of erbB receptor interaction on a cell-by-cell basisSimone Diermeier-Daucher, Max Hasmann, Gero Brockhoff
Histopathology|March 25, 2016
The FlexISH assay brings flexibility to cytogenetic HER2 testingGero Brockhoff, Maria Bock, Florian Zeman, et al.
Mabs|July 24, 2012
Trifunctional antibody ertumaxomab: Non-immunological effects on Her2 receptor activity and downstream signalingSimone Diermeier-Daucher, Olaf Ortmann, Stefan Buchholz, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Current Protocols|November 20, 2023
Complementary Tumor Diagnosis by Single Cell-Based Cytogenetics Using Multi-marker Fluorescence In Situ Hybridization (mFISH)Gero Brockhoff
Oncotarget|May 30, 2019
Target HER four in breast cancer?Gero Brockhoff
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Cytomics and receptor interaction]Gero Brockhoff
Cellular Signalling|July 12, 2022
"Shedding" light on HER4 signaling in normal and malignant breast tissuesGero Brockhoff
Current Protocols in Cytometry|September 5, 2008
Flow cytometric FRET analysis of ErbB receptor tyrosine kinase interactionSimone Diermeier-Daucher, Gero Brockhoff
Current Protocols in Cell Biology|September 21, 2010
Dynamic proliferation assessment in flow cytometrySimone Diermeier-Daucher, Gero Brockhoff
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 13, 2012
Targeting drugs to mitochondriaAnne Heller, Gero Brockhoff, Achim Goepferich
Annals of the New York Academy of Sciences|July 4, 2008
Flow cytometric FRET analysis of erbB receptor interaction on a cell-by-cell basisSimone Diermeier-Daucher, Max Hasmann, Gero Brockhoff
Histopathology|March 25, 2016
The FlexISH assay brings flexibility to cytogenetic HER2 testingGero Brockhoff, Maria Bock, Florian Zeman, et al.
Mabs|July 24, 2012
Trifunctional antibody ertumaxomab: Non-immunological effects on Her2 receptor activity and downstream signalingSimone Diermeier-Daucher, Olaf Ortmann, Stefan Buchholz, et al.
Pageof 9